Literature DB >> 21228772

Understanding eosinophilic esophagitis: the cellular and molecular mechanisms of an emerging disease.

D J Mulder1, C J Justinich.   

Abstract

Eosinophilic esophagitis (EoE) has been increasingly recognized as a unique clinicopathological entity over the past two decades. In this short time, the mechanisms of a complex disease have begun to emerge. Patient studies suggest that EoE is an immunologic disease related to atopy. At the cellular level, eosinophils, mast cells, and B and T lymphocytes are increased in the esophageal mucosa in a patchy distribution throughout the length of the esophagus. Laboratory investigations have implicated aeroallergens, food allergens, and a unique T helper type 2 cytokine profile. EoE appears to be an antigen-driven hypersensitivity reaction characterized by a mixed IgE-dependent/delayed-type reaction and a distinct cascade of cytokines and growth factors. The causative events that lead to EoE in humans remain unknown.

Entities:  

Mesh:

Year:  2011        PMID: 21228772     DOI: 10.1038/mi.2010.88

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  15 in total

1.  Elevated levels of leukotriene C4 synthase mRNA distinguish a subpopulation of eosinophilic oesophagitis patients.

Authors:  W S Lexmond; M Pardo; K Rooney; J A Goettel; S B Snapper; E H Yen; E Dehlink; S Nurko; E Fiebiger
Journal:  Clin Exp Allergy       Date:  2013-08       Impact factor: 5.018

Review 2.  Roles and regulation of gastrointestinal eosinophils in immunity and disease.

Authors:  YunJae Jung; Marc E Rothenberg
Journal:  J Immunol       Date:  2014-08-01       Impact factor: 5.422

3.  Expression of toll-like receptors 2 and 3 on esophageal epithelial cell lines and on eosinophils during esophagitis.

Authors:  Daniel J Mulder; David Lobo; Nanette Mak; Christopher J Justinich
Journal:  Dig Dis Sci       Date:  2011-09-30       Impact factor: 3.199

4.  Pathogen induced chemo-attractant hepoxilin A3 drives neutrophils, but not eosinophils across epithelial barriers.

Authors:  S A Kubala; S U Patil; W G Shreffler; B P Hurley
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-12-04       Impact factor: 3.072

5.  MiR-375 is downregulated in epithelial cells after IL-13 stimulation and regulates an IL-13-induced epithelial transcriptome.

Authors:  T X Lu; E-J Lim; T Wen; A J Plassard; S P Hogan; L J Martin; B J Aronow; M E Rothenberg
Journal:  Mucosal Immunol       Date:  2012-03-28       Impact factor: 7.313

6.  Involvement of the iNKT cell pathway is associated with early-onset eosinophilic esophagitis and response to allergen avoidance therapy.

Authors:  Willem S Lexmond; Joana F Neves; Samuel Nurko; Torsten Olszak; Mark A Exley; Richard S Blumberg; Edda Fiebiger
Journal:  Am J Gastroenterol       Date:  2014-02-11       Impact factor: 10.864

7.  Molecular diagnosis of eosinophilic esophagitis by gene expression profiling.

Authors:  Ting Wen; Emily M Stucke; Tommie M Grotjan; Katherine A Kemme; J Pablo Abonia; Philip E Putnam; James P Franciosi; Jose M Garza; Ajay Kaul; Eileen C King; Margaret H Collins; Jonathan P Kushner; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2013-08-23       Impact factor: 22.682

8.  A pilot study of omalizumab in eosinophilic esophagitis.

Authors:  Denise Loizou; Benjamin Enav; Edina Komlodi-Pasztor; Pamela Hider; Julie Kim-Chang; Laura Noonan; Tabitha Taber; Suhasini Kaushal; Renuka Limgala; Margaret Brown; Raavi Gupta; Nader Balba; Ozlem Goker-Alpan; Amer Khojah; Oral Alpan
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

9.  Biomechanics of esophageal function in eosinophilic esophagitis.

Authors:  Andrew J Read; John E Pandolfino
Journal:  J Neurogastroenterol Motil       Date:  2012-10-09       Impact factor: 4.924

10.  Eosinophilic gastrointestinal diseases: review and update.

Authors:  Mahreema Jawairia; Ghulamullah Shahzad; Paul Mustacchia
Journal:  ISRN Gastroenterol       Date:  2012-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.